In this episode, Marcus and Vic break down the Federal Reserve’s indecision on rate cuts, mass tech layoffs accelerated by AI, and why startups no longer need as much capital. They discuss major VC moves in healthcare, including Tennr, Sword Health, and Nabla, along with General Catalyst’s hospital acquisition. The episode also covers Medicaid cuts, fractures in the Republican party, and the Supreme Court’s decision on gender-affirming care. Plus, stablecoins get a bipartisan boost, AI compan...

In this episode, Vic and Marcus welcome back Tarun Kapoor to discuss the evolution and real-world implementation of AI in healthcare. They explore the lessons learned from Wobo, a digital therapeutic tool, and its regulatory challenges. Tarun shares insights on the future of ambient listening and vision in clinical settings, the rising need for AI infrastructure and oversight, and the shifting standard of care where not using AI could soon be seen as negligent. They also discuss workforce tra...

In this episode, Vic and Marcus discuss their recent selection committee experience, shifting political dynamics affecting tech companies like Uber and Tesla, and the implications of increasing political polarization on consumer behavior. They analyze the economic outlook, including job reports and inflation, and the potential impact on interest rates. The conversation shifts into venture news with funding rounds for health tech and wearable startups, including Guide Health, Somnia, and Eli H...

Vic and Marcus break down the public feud between Elon Musk and Donald Trump, its impact on politics, social media power dynamics, and the fracture between tech elites and MAGA conservatives. They analyze market reactions, including crypto drops and investor concerns, and discuss the broader implications for the Republican party. The episode covers potential risks to Tesla and SpaceX, the debt ceiling crisis, recession indicators from ISM and Beige Book data, concerns over inflation data accu...

Marcus is joined by Emily Evans to break down the sweeping changes proposed under the “Make America Healthy Again” initiative and the "One Big Beautiful Bill." They discuss the healthcare system’s shift from treating sickness to promoting long-term health, the political disruption caused by these policies, the overmedicalization of children, pharma industry challenges, obesity drugs, the role of agriculture and environmental toxins, vaccine policy reform, mental health in youth, and how these...

In this episode, Vic and Marcus cover a wide-ranging set of topics shaping today’s healthcare and economic landscape. They discuss Vic’s personal milestone of becoming an empty nester before diving into Marcus’s experience at a roundtable with HFMA and KPMG, where healthcare leaders confronted the friction between innovation and operational reality. They explore the challenges hospitals face in adopting change amidst massive fixed infrastructure costs, the impact of America’s downgraded credi...

In this episode, Vic Gatto and guest host Rick Abramson, a physician and healthcare strategist, cover the latest in AI regulation, economic indicators affecting healthcare, recent venture deals in senior living and food-as-medicine startups, and growing momentum behind the MAHA (Make America Healthy Again) movement. They discuss controversial federal appointments, shifts in FDA policy, the balance between prevention and treatment, Medicare Advantage fraud allegations, state Medicaid funding l...

In this episode, Vic speaks with Mark Durante, founder of RiseUP Medical, about the cutting-edge world of biologics and regenerative medicine. They explore how biologics like PRP, PRF, stem cells, and exosomes are being applied in areas such as neuropathy, orthopedic injuries, aesthetics, and sexual health. Mark explains the science behind cell therapies, including mesenchymal stem cells and Wharton's Jelly, and discusses RiseUP’s role in bridging labs and physicians to expand treatment optio...

In this episode, Vic and Marcus cover a sweeping range of major developments in healthcare, policy, and the economy. They dive deep into the UnitedHealth Group crisis, discussing the CEO resignation, DOJ investigation, and stock collapse. They analyze inflation data, Microsoft layoffs, and U.S.-China trade pauses, while also breaking down emerging trends in biotech, AI-driven drug development, hospital discharge tech, and venture capital movement. The hosts explore RFK Jr.'s impact on CMS pol...

In this episode, Vic and Marcus cover a wide range of pressing topics including layoffs at UPS, economic instability, and the implications of AI in healthcare and commerce. They discuss new AI-powered voice agents from companies like Zocdoc and Cedar, explore the role of Meta and surveillance technology, and criticize loose AI guardrails on social platforms. The hosts also examine AI’s impact on the audit and pharmaceutical sectors, M&A activity, and the growing use of GLP-1 drugs by athl...

In this episode, Vic sits down with Ben Lytle, founder of Anthem and serial entrepreneur, to discuss the future of healthcare, including AI’s role in solving clinician shortages, the creation of SilverSneakers, and how lifestyle changes can tackle chronic disease. They also cover healthcare system reform, the importance of bounded AI for clinical accuracy, leadership strategies, and how individuals can prepare for rapid societal shifts by building health, financial resilience, and a sense of ...

In this episode, Vic and Marcus cover a wide range of topics including the current state of the U.S. economy, rising tensions and negotiations around tariffs between the U.S. and China, the volatility of the housing market, and recent VC activity across healthcare, nutrition, and biotech. They discuss the Greater Nashville Private Capital Association event, trends in venture capital funding, the impact of political decisions on biotech innovation, Medicaid policy changes, the attack on PBMs, ...

Join Dr Mariele Gatto in conversation with Dr Chris Wincup as they discuss all things related to lupus immunology, from pathogenesis to treatment decisions. Thanks for listening to Talking Rheumatology! Join the conversation on X using #TalkingRheum or tweet us @RheumatologyUK. BSR is the UK's leading specialist medical society for rheumatology and MSK health professionals. To discover how we can support you in delivering the best care for your patients, visit our website.

In this episode, Marcus and Vic break down a whirlwind week across healthcare, policy, economics, and AI. They cover the volatile market reaction to trade tensions and Jerome Powell’s inflation warnings, the downturn in healthcare stocks and payor performance, and continued disruption in the hospital sector. They examine critical funding cuts at HHS, CMS policy shifts, and policy changes affecting food stamps and Medicaid waivers. The conversation also touches on investment rounds in health t...

In this episode of the Health Further podcast, hosts Vic and Marcus sit down with former U.S. Senate Majority Leader and heart transplant surgeon, Senator Bill Frist, to explore the intersection of environmental policy, healthcare, and innovation. Senator Frist discusses his role as Global Board Chair of The Nature Conservancy and why climate change and biodiversity loss are now the greatest threats to human health. He shares stories from his recent trip to the Amazon, the medical breakthroug...

In this episode, Marcus and guest host Paul Kappleman discuss the chaotic pace of global and domestic events impacting healthcare leaders, starting with Donald Trump’s energy and policy unpredictability. They analyze the 90-day tariff pause with China and its effect on the markets, the symbolic rollback of chip restrictions involving Nvidia, and the importance of American manufacturing resilience. The conversation shifts to employer healthcare costs, the Transparent-Accolade merger, and the l...

In this episode, Vic and Marcus sit down with Doba Parushev, Managing Partner at Healthworx, to unpack the distinct differences between traditional and corporate venture capital, particularly within healthcare. Doba shares his career journey from engineering to Latin American VC, through McKinsey and Edison Partners, to leading Healthworx at CareFirst. The conversation covers the pros and cons of corporate VCs for startups, the expectations versus realities of these partnerships, how investme...

Alexandra's on IG:https://www.instagram.com/thealexandragatto/ Alexandra's Website & Offers: https://stan.store/alexandragatto?fbclid=PAZXh0bgNhZW0CMTEAAadirt5SlFMs81NoZM7oMSIRBvJa2vRi-d--3asw-pUe1BJIoEKn6XpBLKQ7CA_aem_ZZAFRTYnZJb0WYAanAaPaA Stephanie's IG: https://www.instagram.com/the.stephanie.eagleson/ Stephanie's Website: https://stephanieeagleson.com/

In this episode, Vic and Marcus focus on the sweeping economic impact of the new “Liberation Day” tariffs, including market reaction, healthcare supply chain disruptions, inflationary concerns, and implications for startups and venture capital. They discuss shrinking margins in healthcare, funding shifts in tech and AI, layoffs at major institutions like Vanderbilt and UnitedHealth, the Circle IPO in the crypto space, and how the AI therapy chatbot study may reshape mental health treatment. T...

In this episode, Marcus and Vic discuss the nonstop barrage of breaking political and economic news, starting with NCAA March Madness brackets and how NIL and the transfer portal have reshaped college sports. They cover February's unexpected 4.2% rise in home sales, Trump's proposed 25% car tariffs, and broader conversations on globalization, economic nationalism, and JD Vance’s key arguments at the American Dynamism conference. The hosts analyze implications of U.S. trade strategies, April's...